← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2008Last known activity
Oct 10, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 9 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05986773CollaboratorPhase 4Oct 10, 2023
- NCT05261516CollaboratorPhase 4Aug 31, 2022
- NCT04836260CollaboratorPhase 3Apr 8, 2021
- NCT04836260Overall official - principal investigatorPhase 3Apr 8, 2021
- NCT04365439Overall official - principal investigatorN/AApr 27, 2020
- NCT02025608Sponsor investigatorPhase 4Dec 1, 2013
- NCT01701856Overall official - principal investigatorPhase 4Sep 1, 2012
- NCT00944957CollaboratorN/ANov 1, 2009
- NCT00908063Overall official - principal investigatorPhase 2Oct 1, 2009
- NCT00792584CollaboratorN/ANov 1, 2008
Details
- Last known activity
- Oct 10, 2023